Index by Author

April 1, 2003; 138 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Al-Sarraf, Muhyi

B

  1. Berl, Tomas

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Besser, Richard E.

  3. Boiardi, Luigi

  4. Borrow, Raymond

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  5. Botkin, Jeffrey R.

    • “Genetic Exceptionalism” in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests[dhelix] Ann Intern Med April 1, 2003 138:571-575

  6. Bridges, Carolyn B.

  7. Brodkin, Henry

C

  1. Cannings, Chris

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  2. Chung, Daniel C.

  3. Cooper, Richard S.

    • Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?[dhelix] Ann Intern Med April 1, 2003 138:576-580

  4. Crick, F.H.C.

  5. Crowther, Mark A.

D

  1. Demicheli, Vittorio

  2. Drury, Paul L.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  3. Duff, Gordon W.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

E

  1. Esmatjes, Enric

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

G

  1. Gandjour, Afschin

  2. Ghirarduzzi, Angelo

  3. Goldhaber, Samuel Z.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  4. Gonzales, Ralph

  5. Green, Michael J.

    • “Genetic Exceptionalism” in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests[dhelix] Ann Intern Med April 1, 2003 138:571-575

  6. Gromnica-Ihle, Erika

H

  1. Hayward, Rodney A.

    • Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med April 1, 2003 138:593-602

  2. Hoagland, Mahlon B.

  3. Hricik, Donald

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  4. Hunsicker, Lawrence G.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

J

  1. Jefferson, Tom

K

  1. Kaczmarski, Edward B.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  2. Keeffe, Emmet B.

  3. Kelley, William N.

L

  1. Landefeld, C. Seth

  2. Lee, Patrick Y.

  3. Lewis, Edmund J.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  4. Lewis, Julia B.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Linder, Jeffrey A.

  6. Liu, Margaret A.

  7. Locatelli, Francesco

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  8. Long, Heather

M

  1. Maheswaran, Ravi

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  2. Meltzer, Martin I.

  3. Mottur-Pilson, Christel

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

N

  1. Naylor, Simone C.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

P

  1. Parikh, Chirag R.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Patel, Amit P.

  3. Peterson, Eric D.

  4. Pfeffer, Marc A.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Porush, Jerome G.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  6. Psaty, Bruce M.

    • Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?[dhelix] Ann Intern Med April 1, 2003 138:576-580

R

  1. Raz, Itamar

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Read, Robert C.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  3. Ringstrom, Elin

  4. Rouleau, Jean-Lucien

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Rustgi, Anil K.

S

  1. Salvarani, Carlo

  2. Schmidt, Wolfgang A.

  3. Snow, Vincenza

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

  4. Srivastava, Indresh K.

  5. Steinman, Michael A.

T

  1. Timms, Janine M.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

V

  1. Vanhille, Philippe

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Vijan, Sandeep

    • Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med April 1, 2003 138:593-602

W

  1. Watson, J.D.

  2. Weideman, Rick

  3. Weiss, Kevin B.

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

  4. Wiegmann, Thomas B.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Wolfe, Bernard M.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

Current Issue

  1. December 15, 2009, 151 (12)
  1. Alert me to current issues